YOLFTbeta
DIVA Laboratories Ltd

DIVA Laboratories Ltd

4153 · TWO · Healthcare / Diagnostics & Research

31.10TWD+0.75 (+2.47%)

Price History

Full chart

Market Stats

Previous Close30.35
Open30.10
Day Range30.10 – 31.30
52-Week Range29.00 – 38.80
Volume23.10K
Market Cap1.85B
P/E (TTM)19.36
Forward P/E0.00
EPS1.63
Dividend Yield6.34%
Beta0.17
50-Day Avg32.29
200-Day Avg32.43

About

DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is headquartered in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOChen Gene
  • Employees0
  • HeadquartersNo. 351, Zhongshan Rd., New Taipei City, Taiwan, 235602, Taiwan
  • Websitehttps://www.diva.com.tw

Leadership

  • Chen GeneVice Chairman & CEO
  • Peter ChangChief Operating Officer
  • Su Ru LinAccounting Supervisor
  • James ChenVP & CTO
  • Jun Xian LiDirector of the Information Department
  • Jian Gen ZhangDeputy General Manager of the Development Department
  • Kenneth ChenChief SO

Financials

Income Statement

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue857.00M650.13M716.17M736.92M712.23M949.20M893.84M862.32M868.84M
Growth (%)--24.14%+10.16%+2.90%-3.35%+33.27%-5.83%-3.53%+0.76%
Cost of Revenue675.26M445.47M491.33M523.26M530.64M683.07M643.07M602.14M604.70M
Gross Profit181.74M204.67M224.84M213.66M181.60M266.13M250.77M260.18M264.14M
Gross Margin21.21%31.48%31.39%28.99%25.50%28.04%28.06%30.17%30.40%
Operating Expense225.14M159.23M160.24M154.98M156.90M143.95M154.17M157.61M154.78M
Operating Income-43.40M45.44M64.60M58.69M24.69M122.18M96.60M102.57M109.36M
Operating Margin-5.06%6.99%9.02%7.96%3.47%12.87%10.81%11.89%12.59%
EBITDA-257.98M80.20M84.06M77.72M38.40M132.28M97.16M127.10M119.15M
EBITDA Margin-30.10%12.34%11.74%10.55%5.39%13.94%10.87%14.74%13.71%
Net Income-267.15M52.15M56.04M17.42M21.86M49.66M73.62M93.66M90.54M
Net Income Margin-31.17%8.02%7.83%2.36%3.07%5.23%8.24%10.86%10.42%
R&D78.08M64.66M63.42M61.58M69.52M82.62M69.16M71.90M72.46M
R&D as % of Total Revenue9.11%9.95%8.86%8.36%9.76%8.70%7.74%8.34%8.34%
Interest Expense0115.00K1.00K57.00K110.00K201.00K329.00K205.00K240.00K
Interest Expense % of Total Revenue0.00%0.02%0.00%0.01%0.02%0.02%0.04%0.02%0.03%

Balance Sheet

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.06B1.32B1.30B1.11B1.18B1.25B1.24B1.31B1.35B
Total Liabilities254.84M138.87M168.09M124.34M195.27M235.62M210.93M249.94M324.52M
Total Equity806.75M1.18B1.13B988.89M986.42M1.02B1.03B1.06B1.03B
Cash280.93M611.37M506.65M323.75M299.27M346.37M536.92M589.14M494.03M
Total Debt--21.00K537.00K411.00K283.00K---
Net Debt---506.63M-323.22M-298.86M-346.08M---

Cash Flow

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow41.45M86.02M52.66M-16.64M-11.39M73.19M252.91M123.14M20.77M
Investing Cash Flow-114.85M39.38M-51.92M-5.29M2.62M-5.05M---
Financing Cash Flow-64.53M204.45M-106.73M-160.72M-15.49M-22.04M---
Capital Expenditure13.31M21.71M12.79M21.76M12.85M11.42M7.69M2.13M1.00M
Free Cash Flow23.14M61.83M39.87M-38.41M-24.24M61.77M245.23M121.01M19.77M
Dividends Paid106.60M106.60M106.60M15.25M15.25M21.71M58.67M73.33M117.34M
FCF to OCF55.82%71.88%75.70%230.74%212.82%84.40%96.96%98.27%95.19%
Dividend Paid to FCF460.75%172.42%267.39%-39.72%-62.93%35.14%23.92%60.60%593.54%

Earnings

Report DateMay 29, 2013Jul 29, 2013Oct 27, 2013Feb 26, 2014May 14, 2014Aug 12, 2014Nov 6, 2014Mar 18, 2015May 15, 2015Aug 14, 2015Nov 14, 2015Mar 31, 2016May 16, 2016Aug 15, 2016Nov 14, 2016Mar 31, 2017May 15, 2017Aug 11, 2017Nov 13, 2017Feb 28, 2018May 15, 2018Aug 13, 2018Nov 13, 2018Feb 27, 2019May 15, 2019Aug 14, 2019Nov 13, 2019Mar 9, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021Jun 2, 2021Sep 1, 2021Dec 1, 2021Mar 2, 2022Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 1, 2023May 31, 2023
EPS Estimate-0.470.31-0.530.840.610.720.961.141.38-0.761.10---0.080.71------0.320.470.37--------------
EPS Actual0.640.730.560.340.680.651.150.940.601.201.440.63-0.090.60-0.43-2.42-1.620.71-4.47-1.270.260.410.130.070.410.350.22-0.020.010.350.02-0.090.000.110.27-0.010.030.060.380.370.36
Surprise-55.32%80.65%-28.30%-22.62%88.52%30.56%-37.50%5.26%4.35%--111.84%-45.45%---1925.00%0.00%------28.13%-25.53%-40.54%--------------
Timing-After-hoursAfter-hours-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hoursPre-market-------------

Key Statistics & Ratios

Market Cap1.85B
Enterprise Value1.34B
Trailing P/E19.36
Forward P/E0.00
Price / Sales2.07
Price / Book1.95
EPS1.63
Book Value16.49
Revenue (TTM)894.67M
Gross Profit (TTM)257.66M
EBITDA106.43M
Profit Margin10.73%
Operating Margin12.83%
Return on Equity9.84%
Return on Assets4.34%
Shares Outstanding58.67M
Shares Float22.44M
Beta0.17
Dividend Yield6.34%
Dividend Rate2.00
Payout Ratio122.48%

Dividends

20261×
2.00Jun 12, 2026
20251×
2.00Jun 13, 2025
20241×
1.25Jun 19, 2024
20231×
1.00Jul 4, 2023
20221×
0.37Jul 4, 2022
20211×
0.26Nov 12, 2021
20201×
1.99Oct 8, 2020
20191×
1.77Jun 25, 2019
20161×
3.13Aug 15, 2016
20151×
2.46Aug 13, 2015
20141×
1.39Sep 30, 2014
20131×
0.40Sep 3, 2013
20121×
0.37Sep 4, 2012

Stock Splits

  • Oct 8, 2020834.2489:1000
  • Aug 15, 20161150:1000
  • Aug 13, 20151098.529:1000
  • Sep 30, 20141157.248:1000
  • Sep 3, 20131.0483:1
  • Sep 4, 20121.05:1